Carotid Stents

Global Carotid Stents Market to Reach US$6.3 Billion by 2030

The global market for Carotid Stents estimated at US$3.9 Billion in the year 2024, is expected to reach US$6.3 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the analysis period. Growth in the Self-Expanding Stents segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 12.2% CAGR

The Carotid Stents market in the U.S. is estimated at US$1.0 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 12.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.0% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

strong>Global Carotid Stents Market - Key Trends & Drivers Summarized

What Are Carotid Stents and How Do They Prevent Stroke?
Carotid stents are small, flexible tubes used to open narrowed carotid arteries, which are located on each side of the neck and are the primary suppliers of blood to the brain. The procedure to place a stent, known as carotid artery stenting, is a common treatment for carotid artery disease, a major risk factor for stroke. The stenting helps prevent stroke by alleviating obstructions in the carotid arteries, allowing for unimpeded blood flow. This is typically done in conjunction with a technique called angioplasty, where a balloon is used to expand the artery before a stent is placed. This method is particularly advantageous for patients considered at high risk for traditional carotid surgery, offering a minimally invasive alternative with comparable outcomes.

How Is Technological Advancement Enhancing Carotid Stent Procedures?
Technological advancements are significantly enhancing the safety and efficacy of carotid stenting procedures. Innovations in stent design, such as the introduction of dual-layer stents and those made from bioabsorbable materials, promise better compatibility with the body and reduced risk of future blockages or complications. Imaging technologies like advanced ultrasound, MRI, and real-time monitoring during stenting procedures have improved dramatically, allowing surgeons to achieve more precise placements of stents. Furthermore, developments in robotic surgery are beginning to permeate the field, potentially offering even greater precision, reduced recovery times, and minimal surgical risks. These technological enhancements contribute to better patient outcomes and have increased the acceptance of carotid stenting as a safe alternative to surgical procedures.

What Are the Current Trends Impacting the Carotid Stents Industry?
Several current trends are influencing the carotid stents industry, driven by demographic, technological, and regulatory factors. The aging global population is a significant driver, as older adults are more prone to carotid artery disease. There is also a growing preference for minimally invasive surgeries over traditional surgical methods, particularly among patients with multiple comorbidities for whom surgery poses high risks. In response to these trends, there is an increasing demand for more advanced, patient-friendly stenting options that offer reduced recovery times and lower risk of complications. Regulatory trends are also shaping the industry, as governments and healthcare bodies increase scrutiny and demand higher standards of efficacy and safety for medical devices used in critical care settings.

What Drives the Growth of the Carotid Stents Market?
The growth in the carotid stents market is driven by several factors, including technological innovations that have improved the safety and efficacy of stent implants. An increase in the prevalence of cardiovascular diseases and stroke risk among the aging population worldwide necessitates effective interventions like carotid stenting. There is also a growing body of clinical evidence supporting the long-term benefits of carotid stenting over alternative surgical methods, which bolsters its adoption among healthcare providers. Additionally, advancements in medical imaging and surgical techniques have expanded the potential patient base for carotid stenting by enabling the treatment of cases that were previously deemed unsuitable for this approach. Consumer behavior that increasingly favors minimally invasive treatments with shorter hospital stays and recovery times also contributes to the rising demand for carotid stenting procedures.

SCOPE OF STUDY:

The report analyzes the Carotid Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Balloon Expandable Stents, Self-Expanding Stents)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

• Abbott Laboratories, Inc.
• Balton Sp z o.o.
• Boston Scientific Corporation
• Cardinal Health, Inc.
• InspireMD Inc.
• Medtronic PLC
• Optimed Medizinische Instrumente GmbH
• Terumo Europe NV
• W. L. Gore & Associates, Inc.

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more